Robert J Gould's Net Worth

Robert J Gould's net worth is estimated to be at least $6,449,192.89 as of 11/09/2024. CoreStreet's estimation of Robert J Gould's net worth is based on their sale of stock and current holding of stock.

Robert J Gould is CEO at Fulcrum Therapeutics Inc. They have executed at least 16 trades of stock as per SEC Form 4 filings. Their most recent trade was for 6,766 units of FULC stock on 01/13/2023. Their biggest sale was on 07/06/2015 when they sold 60,000 units of Epizyme Inc stock for $1,393,200.00. They typically trade 2 times per year.

Total value of insider buys:
  • $0.00
Total value of insider sells:
  • $6,449,192.89
Most recent insider trade:
  • Jan. 13, 2023

Robert J Gould's Insider Trading History

Fulcrum Therapeutics IncTitleAmountPriceTypeTotal Value
Jan. 13, 2023
CEO6,766$15.00Sell$101,490.00
June 6, 2022
Director24,382$8.10Sell$197,494.20
June 3, 2022
Director25,551$7.95Sell$203,130.45
April 4, 2022
Director7,235$24.02Sell$173,784.70
April 1, 2022
Director34,464$24.03Sell$828,169.92
March 15, 2021
Insider9,211$12.13Sell$111,729.43
Jan. 20, 2021
Insider10,000$12.08Sell$120,800.00
July 8, 2020
Insider2,500$20.00Sell$50,000.00
June 25, 2020
Insider2,500$20.80Sell$52,000.00
June 3, 2020
Insider1,500$20.13Sell$30,195.00
May 28, 2020
Insider1,919$20.01Sell$38,399.19
Epizyme IncTitleAmountPriceTypeTotal Value
July 6, 2015
CEO60,000$23.22Sell$1,393,200.00
Nov. 3, 2014
CEO30,000$24.95Sell$748,500.00
Oct. 1, 2014
CEO30,000$26.28Sell$788,400.00
July 1, 2014
CEO30,000$31.53Sell$945,900.00
June 2, 2014
CEO30,000$22.20Sell$666,000.00